Vito Lampasona

9.4k total citations · 1 hit paper
100 papers, 3.5k citations indexed

About

Vito Lampasona is a scholar working on Genetics, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Vito Lampasona has authored 100 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Genetics, 51 papers in Surgery and 30 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Vito Lampasona's work include Diabetes and associated disorders (60 papers), Pancreatic function and diabetes (44 papers) and Diabetes Management and Research (25 papers). Vito Lampasona is often cited by papers focused on Diabetes and associated disorders (60 papers), Pancreatic function and diabetes (44 papers) and Diabetes Management and Research (25 papers). Vito Lampasona collaborates with scholars based in Italy, Germany and United States. Vito Lampasona's co-authors include Ezio Bonifacio, Emanuele Bosi, Elena Bazzigaluppi, Stefano Genovese, Lorenzo Piemonti, Maurizio Ferrari, Daniela Liberati, Cristina Brigatti, Peter Achenbach and G Chiumello and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Blood.

In The Last Decade

Vito Lampasona

95 papers receiving 3.4k citations

Hit Papers

Neutralizing antibody responses to SARS-CoV-2 in symptoma... 2021 2026 2022 2024 2021 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival
    2021 222 citations Stefania Dispinseri, Massimiliano Secchi et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vito Lampasona Italy 34 2.0k 1.7k 1.3k 518 512 100 3.5k
Nicole Fabien France 35 729 0.4× 512 0.3× 490 0.4× 740 1.4× 894 1.7× 146 3.7k
G. F. Bottazzo United Kingdom 36 2.5k 1.2× 1.6k 0.9× 2.5k 1.9× 431 0.8× 1.1k 2.2× 101 4.3k
Janette Allison Australia 31 1.5k 0.8× 1.1k 0.6× 539 0.4× 781 1.5× 1.8k 3.5× 47 3.4k
Benedicte A. Lie Norway 30 943 0.5× 428 0.2× 294 0.2× 596 1.2× 1.1k 2.2× 98 2.6k
G. F. Bottazzo United Kingdom 30 1.1k 0.6× 596 0.3× 1.2k 0.9× 379 0.7× 986 1.9× 65 3.2k
Denise L. Faustman United States 28 1.2k 0.6× 890 0.5× 593 0.4× 724 1.4× 1.5k 3.0× 83 3.1k
GianFranco Bottazzo United Kingdom 12 1.6k 0.8× 1.3k 0.7× 1.3k 1.0× 274 0.5× 829 1.6× 16 3.1k
Stuart P. Berzins Australia 33 890 0.4× 299 0.2× 862 0.6× 766 1.5× 5.0k 9.8× 64 6.4k
Tihamer Orban United States 24 2.2k 1.1× 1.7k 1.0× 1.4k 1.1× 580 1.1× 1.3k 2.6× 38 3.5k
Matthew J. Simmonds United Kingdom 25 1.0k 0.5× 260 0.1× 755 0.6× 393 0.8× 892 1.7× 50 2.5k

Countries citing papers authored by Vito Lampasona

Since Specialization
Citations

This map shows the geographic impact of Vito Lampasona's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vito Lampasona with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vito Lampasona more than expected).

Fields of papers citing papers by Vito Lampasona

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vito Lampasona. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vito Lampasona. The network helps show where Vito Lampasona may publish in the future.

Co-authorship network of co-authors of Vito Lampasona

This figure shows the co-authorship network connecting the top 25 collaborators of Vito Lampasona. A scholar is included among the top collaborators of Vito Lampasona based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vito Lampasona. Vito Lampasona is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bonifacio, Ezio, Przemysława Jarosz‐Chobot, Mirjam Kohls, et al.. (2025). The efficacy of islet autoantibody screening with or without genetic pre-screening strategies for the identification of presymptomatic type 1 diabetes. Diabetologia. 68(6). 1101–1107. 2 indexed citations
2.
Krischer, Jeffrey P., Sarah Müller, Peter Achenbach, et al.. (2025). Comparative Analysis of the Sensitivity, Specificity, Concordance, and 5-Year Predictive Power of Diabetes-Related Autoantibody Assays. Diabetes. 74(9). 1535–1546.
3.
Vincentini, Olimpia, Flavia Pricci, Marco Silano, et al.. (2025). Study protocol of D1Ce Screen: A pilot project of the Italian national screening program for type 1 diabetes and coeliac disease in the paediatric population. PLoS ONE. 20(8). e0328624–e0328624. 1 indexed citations
4.
Piemonti, Lorenzo, Andrea Mario Bolla, Amelia Caretto, et al.. (2025). Induction of immune education in type 1 diabetes through controlled allogeneic islet rejection at onset: a monocentric open-label pilot study. EClinicalMedicine. 90. 103685–103685.
5.
Cherubini, Valentino, Enza Mozzillo, Dario Iafusco, et al.. (2024). Follow‐up and monitoring programme in children identified in early‐stage type 1 diabetes during screening in the general population of Italy. Diabetes Obesity and Metabolism. 26(10). 4197–4202. 13 indexed citations
6.
Citro, Antonio, Cataldo Pignatelli, Matteo Monieri, et al.. (2023). Directed self-assembly of a xenogeneic vascularized endocrine pancreas for type 1 diabetes. Nature Communications. 14(1). 878–878. 24 indexed citations
7.
Calvisi, Stefania, Giuseppe A. Ramirez, Marina Scavini, et al.. (2021). Thromboembolism risk among patients with diabetes/stress hyperglycemia and COVID-19. Metabolism. 123. 154845–154845. 22 indexed citations
8.
Dispinseri, Stefania, Vito Lampasona, Massimiliano Secchi, et al.. (2021). Robust Neutralizing Antibodies to SARS-CoV-2 Develop and Persist in Subjects with Diabetes and COVID-19 Pneumonia. The Journal of Clinical Endocrinology & Metabolism. 106(5). 1472–1481. 35 indexed citations
9.
Dispinseri, Stefania, Massimiliano Secchi, Maria Franca Pirillo, et al.. (2021). Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival. Nature Communications. 12(1). 2670–2670. 222 indexed citations breakdown →
10.
McLaughlin, Katherine A., Diego Liberati, Vito Lampasona, Richard Feltbower, & M. R. Christie. (2018). Autoantibody reactivity to tetraspanin-7 is directed to the cytoplasmic domains: Implications for immunoassay design. Diabetic Medicine. 35. 67–67. 2 indexed citations
11.
Lampasona, Vito, et al.. (2018). Shelf Life and Efficacy of Diagnostic Eye Drops. Optometry and Vision Science. 95(10). 947–952. 5 indexed citations
12.
Achenbach, Peter, Mohammed I. Hawa, Stephanie Krause, et al.. (2018). Autoantibodies to N-terminally truncated GAD improve clinical phenotyping of individuals with adult-onset diabetes: Action LADA 12. Diabetologia. 61(7). 1644–1649. 35 indexed citations
13.
Lahner, Edith, Cristina Brigatti, Ilaria Marzinotto, et al.. (2017). Luminescent Immunoprecipitation System (LIPS) for Detection of Autoantibodies Against ATP4A and ATP4B Subunits of Gastric Proton Pump H+,K+-ATPase in Atrophic Body Gastritis Patients. Clinical and Translational Gastroenterology. 8(1). e215–e215. 26 indexed citations
14.
Reni, Michele, Erica Dugnani, Stefano Cereda, et al.. (2015). (Ir)relevance of Metformin Treatment in Patients with Metastatic Pancreatic Cancer: An Open-Label, Randomized Phase II Trial. Clinical Cancer Research. 22(5). 1076–1085. 140 indexed citations
15.
Mercalli, Alessia, Vito Lampasona, Karin Klingel, et al.. (2012). No evidence of enteroviruses in the intestine of patients with type 1 diabetes. Diabetologia. 55(9). 2479–2488. 29 indexed citations
16.
17.
Piquer, Sandra, Vito Lampasona, Claude Granier, et al.. (2006). Monoclonal antibody 76F distinguishes IA-2 from IA-2β and overlaps an autoantibody epitope. Journal of Autoimmunity. 26(3). 215–222. 15 indexed citations
18.
19.
Esposito, Laura, Vito Lampasona, Emanuele Bosi, et al.. (1995). HLA DQA1-DQB1-TAP2 haplotypes in IDDM families: no evidence for an additional contribution to disease risk by the TAP2 locus. Diabetologia. 38(8). 968–974. 13 indexed citations
20.
Lampasona, Vito, Maurizio Ferrari, Ezio Bonifacio, et al.. (1995). HLA-DQ screening for risk assessment of insulin dependent diabetes in northern Italy. Acta Diabetologica. 32(3). 137–142. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicole Fabien Breakdown of academic impact, for papers by G. F. Bottazzo Breakdown of academic impact, for papers by Janette Allison Breakdown of academic impact, for papers by Benedicte A. Lie Breakdown of academic impact, for papers by G. F. Bottazzo Breakdown of academic impact, for papers by Denise L. Faustman Breakdown of academic impact, for papers by GianFranco Bottazzo Breakdown of academic impact, for papers by Stuart P. Berzins Breakdown of academic impact, for papers by Tihamer Orban Breakdown of academic impact, for papers by Matthew J. Simmonds
Rankless by CCL
2026